Qualigen is rapidly developing additional desktop blood testing systems for rapid blood tests.  Sekisu Diagnostics, LLC a worldwide supplier of diagnostic equipment and compounds, is a major investor in Qualigen.  The terms of the partnership deal include that Sekisu funded 100% of the development cost of Qualigen’s new FastPack2.0, third generation system which includes a newly patented technology for blood testing of whole blood samples in small quantities.  You can learn more about Qualigen from their website at www.qualigen.com.